[HTML][HTML] Unleashing novel horizons in advanced prostate cancer treatment: investigating the potential of prostate specific membrane antigen-targeted nanomedicine …
M He, Y Cao, C Chi, J Zhao, E Chong… - Frontiers in …, 2023 - frontiersin.org
Prostate cancer (PCa) is a prevalent malignancy with increasing incidence in middle-aged
and older men. Despite various treatment options, advanced metastatic PCa remains …
and older men. Despite various treatment options, advanced metastatic PCa remains …
Exploring Immunological Effects and Novel Immune Adjuvants in Immunotherapy for Salivary Gland Cancers
R Sato, H Yamaki, H Komatsuda, R Wakisaka, T Inoue… - Cancers, 2024 - mdpi.com
Simple Summary The efficacy of immunotherapies in salivary gland cancer (SGC) remains
controversial. To optimize immunotherapy, understanding the tumor microenvironment …
controversial. To optimize immunotherapy, understanding the tumor microenvironment …
[HTML][HTML] Advancements in nanomedicine: Precision delivery strategies for male pelvic malignancies–Spotlight on prostate and colorectal cancer
G Yang, Y Cao, X Yang, T Cui, NZV Tan, YK Lim… - Experimental and …, 2024 - Elsevier
Background Pelvic malignancies consistently pose significant global health challenges,
adversely affecting the well-being of the male population. It is anticipated that clinicians will …
adversely affecting the well-being of the male population. It is anticipated that clinicians will …